Revolution Medicines, Warrant Stock Market Value
| RVMDW Stock | 0.32 0.08 20.00% |
| Symbol | Revolution |
Revolution Medicines, Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revolution Medicines,. If investors know Revolution will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revolution Medicines, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.005 | Return On Assets (0.29) | Return On Equity (0.47) |
The market value of Revolution Medicines, is measured differently than its book value, which is the value of Revolution that is recorded on the company's balance sheet. Investors also form their own opinion of Revolution Medicines,'s value that differs from its market value or its book value, called intrinsic value, which is Revolution Medicines,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revolution Medicines,'s market value can be influenced by many factors that don't directly affect Revolution Medicines,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revolution Medicines,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Revolution Medicines, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revolution Medicines,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Revolution Medicines, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Revolution Medicines,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Revolution Medicines,.
| 07/20/2023 |
| 12/11/2024 |
If you would invest 0.00 in Revolution Medicines, on July 20, 2023 and sell it all today you would earn a total of 0.00 from holding Revolution Medicines, Warrant or generate 0.0% return on investment in Revolution Medicines, over 510 days. Revolution Medicines, is related to or competes with Alvotech, European Wax, Inter Parfums, Coty, Amgen, and Skechers USA. Revolution Medicines, is entity of United States More
Revolution Medicines, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Revolution Medicines,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Revolution Medicines, Warrant upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 17.2 | |||
| Information Ratio | 0.1859 | |||
| Maximum Drawdown | 98.64 | |||
| Value At Risk | (23.64) | |||
| Potential Upside | 47.97 |
Revolution Medicines, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Revolution Medicines,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Revolution Medicines,'s standard deviation. In reality, there are many statistical measures that can use Revolution Medicines, historical prices to predict the future Revolution Medicines,'s volatility.| Risk Adjusted Performance | 0.148 | |||
| Jensen Alpha | 4.0 | |||
| Total Risk Alpha | 0.7181 | |||
| Sortino Ratio | 0.2374 | |||
| Treynor Ratio | 2.43 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Revolution Medicines,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Revolution Medicines, Backtested Returns
Revolution Medicines, is out of control given 3 months investment horizon. Revolution Medicines, maintains Sharpe Ratio (i.e., Efficiency) of 0.2, which implies the firm had a 0.2% return per unit of risk over the last 3 months. We were able to break down twenty-eight different technical indicators, which can help you to evaluate if expected returns of 4.55% are justified by taking the suggested risk. Use Revolution Medicines, Risk Adjusted Performance of 0.148, semi deviation of 12.56, and Coefficient Of Variation of 522.02 to evaluate company specific risk that cannot be diversified away. Revolution Medicines, holds a performance score of 15 on a scale of zero to a hundred. The company holds a Beta of 1.73, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Revolution Medicines, will likely underperform. Use Revolution Medicines, treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to analyze future returns on Revolution Medicines,.
Auto-correlation | 0.35 |
Below average predictability
Revolution Medicines, Warrant has below average predictability. Overlapping area represents the amount of predictability between Revolution Medicines, time series from 20th of July 2023 to 31st of March 2024 and 31st of March 2024 to 11th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Revolution Medicines, price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current Revolution Medicines, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Revolution Medicines, lagged returns against current returns
Autocorrelation, which is Revolution Medicines, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Revolution Medicines,'s stock expected returns. We can calculate the autocorrelation of Revolution Medicines, returns to help us make a trade decision. For example, suppose you find that Revolution Medicines, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Revolution Medicines, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Revolution Medicines, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Revolution Medicines, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Revolution Medicines, stock over time.
Current vs Lagged Prices |
| Timeline |
Revolution Medicines, Lagged Returns
When evaluating Revolution Medicines,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Revolution Medicines, stock have on its future price. Revolution Medicines, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Revolution Medicines, autocorrelation shows the relationship between Revolution Medicines, stock current value and its past values and can show if there is a momentum factor associated with investing in Revolution Medicines, Warrant.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.